Skip to main content
Skip to footer

Teaching Pharmacovigilance to Machines

Dr. Ashish Indani

Head, Research & Innovation, TCS ADD Life Sciences Platform

Dr. Aparna Patkar

Delivery Head and Sr. Domain Consultant, TCS Life Sciences

Devraj Goulikar

Head of Safety Solutions, TCS ADD Life Sciences Platform

You have these already downloaded

We have sent you a copy of the report to your email again.

Artificial intelligence in pharmacovigilance (PV) has the potential to disrupt life sciences industry while making the process quicker and data driven. This paper explores the role of AI in PV with special emphasis on ‘learning’-based observational processing. The system bundles the proprietary best-in-class natural language processing (NLP) and AI technologies capable of cleaning and contextually analyzing PV data identifying trends and outliers, including signals that can impact patient safety. Leveraging a combination of rule-based deterministic and probabilistic approaches to abstract patient data, medical events, drug, and reporter information. The most efficient results are produced when AI and PV professionals work closely in a symbiotic relationship where the bulk-processing is handled by AI systems, thus contributing to precise, quick, and informed decision-making by the pharmacovigilance professionals (PVP).

Related reading

Life Sciences Hilde Vanaken

Harmonization of eConsent The Key to Success

White Paper | 31 Aug 2023
TCS ADD™ Alejandra Guerchicoff Narayanan R Tejas Almelkar

Transforming PV Efficiencies with ML and Rule-based Automation

White Paper | 18 Aug 2023
TCS ADD™ Prasoon Sangwan

Digital Data Flow and Technological Solution Providers

Article | 28 Jun 2023
TCS ADD™

Next-gen clinical trials on a digital platform

Customer Testimonial | 27 Jan 2023